Form 4: Amylyx Director Gifts 17,780 Shares of Common Stock

Amylyx Pharmaceuticals Director George M. Milne Jr. gifted 17,780 shares of common stock on January 12, 2026.

Summary

• George M. Milne Jr., a Director of Amylyx Pharmaceuticals, Inc. (AMLX), reported a transaction.
• On January 12, 2026, Mr. Milne disposed of 17,780 shares of common stock.
• The transaction was a bona fide gift for no consideration, meaning the price per share was $0.00.
• Following this transaction, Mr. Milne beneficially owns 812,881 shares of Amylyx Pharmaceuticals common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a director's gift of shares, which is a neutral event regarding the company's operational or financial performance. It reflects an individual's personal financial decision rather than a corporate strategic move.

Future Outlook

This filing is an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction filing (Form 4) reporting a director's gift of shares. It does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact as the transaction is a gift from a director and does not reflect a change in company fundamentals or strategy. The director's overall beneficial ownership remains substantial.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

Keywords

Amylyx Pharmaceuticals, AMLX, Insider Transaction, Form 4, Director, Stock Gift, Beneficial Ownership